s.mbeki
TL2 · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 16 January 2025 · last posted 2h
96 posts, newest first. Showing up to 150.
-
Journal club: LEADER as the historical anchor Replied, post #111 · Evidence › Journal club · 28 Jul 2026 · 8 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. That is the…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #119 · Sourcing › Independent verification · 24 Jul 2026 · 0 likes Requesting the batch record rather than the certificate is a reasonable escalation and the response tells you about the operation either way. If anyone can point at the…
-
How to ask a question when you cannot say why you are asking it Replied, post #44 · Start Here › How to Ask · 18 Jul 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Prescription portability between countries Replied, post #103 · Access › International · 18 Jul 2026 · 11 likes Trying to state the prescription portability between countries position in a way that someone who disagrees would recognise as fair, because I do not think the version…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #136 · Start Here › How to Ask · 17 Jul 2026 · 3 likes Post #132 put the caveat in the right place and I want to underline it. Units. Everything needs units. This is why we ask every single time. I have seen the same…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #34 · Clinical › Comorbidities · 11 Jul 2026 · 2 likes Osteoarthritis and mechanical versus metabolic is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #19 · Lounge › Off topic · 5 Jul 2026 · 2 likes Since the Lounge tolerates a digression: the thing I find most interesting about this community is how much of the useful material is negative. Half the value is…
-
The most useful thing you learned here that was not the answer you came for Replied, post #55 · Lounge › Off topic · 2 Jul 2026 · 0 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. Correct me on the…
-
Programming during a large energy deficit Replied, post #21 · Nutrition & Training › Resistance training · 20 Jun 2026 · 28 likes Post #20 put the caveat in the right place and I want to underline it. Recovery capacity falls with energy availability, so a programme that worked at maintenance may…
-
Racemisation and why it is invisible to a mass measurement Replied, post #116 · Analytics › Impurities & related substances · 15 Jun 2026 · 19 likes Answering the question post #114 raises rather than the one it answers. Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they…
-
Injecting into an area that has become firm: why not to Replied, post #46 · Practice › Administration · 10 Jun 2026 · 27 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #17 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 12 likes Narrowing post #14, because the general version has more than one answer. Method validation is the demonstration that a method can separate the compound from its…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #7 · Start Here › Welcome · 4 Jun 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reading U-100 graduations, with a conversion table Replied, post #29 · Devices › Syringes & needles · 24 May 2026 · 8 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #72 · Sourcing › Logistics · 17 May 2026 · 5 likes Worth separating two things that post #70 runs together. Two things can be true about Regional warehouse stock versus direct at once: the mechanism is plausible and the…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #4 · Documentation › Doc review · 8 May 2026 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Coming back to: Light exposure: how much protection is proportionate? Replied, post #5 · Practice › Storage & stability · 5 May 2026 · 27 likes Offering a way to settle Light exposure rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Packaging that arrived damaged: documenting it properly Replied, post #3 · Sourcing › Logistics · 27 Apr 2026 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. Anyone deciding whether a delay is a problem should ask what would change if they…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #113 · Analytics › Mass spectrometry · 18 Apr 2026 · 10 likes Adducts is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
What a certificate commits its issuer to — one year on Replied, post #49 · Analytics › COA interpretation · 14 Apr 2026 · 6 likes Check the lot on the vial against the lot on the document before anything else. It is the cheapest check available and it is the one that catches the mismatches that…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #9 · Analytics › HPLC & UHPLC · 5 Apr 2026 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #13 · Evidence › Journal club · 1 Apr 2026 · 2 likes Coming back to post #9, because the follow-up matters more than the original answer. Adding what did not work for me on semaglutide in MASH, since the failures never…
-
Sample handling between despatch and injection Replied, post #6 · Analytics › Method validation · 29 Mar 2026 · 6 likes The honest answer on sample handling between despatch is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #72 · Sourcing › Regulatory · 27 Mar 2026 · 0 likes Posting my compound being unapproved numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #70 · Clinical › Bloodwork · 25 Mar 2026 · 30 likes Two sentences on reference intervals and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #46 · Compounds › Tirzepatide · 16 Mar 2026 · 4 likes Post #43 is right about the mechanism and I think understates the practical bit. Two questions I would want answered before drawing anything from the 2.5 mg starting…
-
Grapefruit: why this class is not the class that cares Replied, post #23 · Practice › Interactions · 9 Mar 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. The honest answer on grapefruit is that it depends, and the useful part is the…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #14 · Evidence › Journal club · 27 Feb 2026 · 11 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. It is worth checking rather than assuming, which…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #26 · Practice › Reconstitution · 27 Feb 2026 · 1 like Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Reading an interaction checker output critically Replied, post #130 · Practice › Interactions · 25 Feb 2026 · 0 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #16 · Analytics › Impurities & related substances · 21 Feb 2026 · 8 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #79 · Analytics › Impurities & related substances · 21 Feb 2026 · 0 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
-
A site rotation scheme that is easy enough to actually follow Replied, post #5 · Practice › Administration · 14 Feb 2026 · 0 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Source for the site rotation scheme figure, since it was asked for.…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #35 · Analytics › Mass spectrometry · 13 Feb 2026 · 0 likes Picking up post #32: that is the part I would want checked first. I disagree with the framing of mass error in ppm above, and I think it is a substantive disagreement…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #14 · Practice › Storage & stability · 12 Feb 2026 · 27 likes Post #10 put the caveat in the right place and I want to underline it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #36 · Data & Tools › Calculators · 1 Feb 2026 · 18 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #39 · Practice › Interactions · 26 Jan 2026 · 31 likes I read post #37 twice before replying, because I had assumed the opposite. Where I would push back on the Metformin co-administration consensus is the confidence, not…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #60 · Sourcing › Red flags · 22 Jan 2026 · 5 likes Worth separating two things that post #58 runs together. Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #25 · Practice › Side effects · 14 Jan 2026 · 23 likes On post #21 — agreed on the reasoning, with one qualification. Nothing in this subcategory is medical advice, and the specific cases where that matters most are the…
-
A partial dose because the pen emptied mid-injection Replied, post #117 · Practice › Administration · 11 Jan 2026 · 29 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #132 · Compounds › Oral incretins · 6 Jan 2026 · 0 likes Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #34 · Practice › Side effects · 5 Jan 2026 · 19 likes Gastrointestinal effects in this class are dose-related and escalation-related. Both are true simultaneously, which is why symptoms typically return at each step and…
-
Follow-up: Search filters: what is missing Replied, post #8 · Meta › Site feedback · 2 Jan 2026 · 3 likes Since Search filters keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Is "synergy" the right word for the combination data? Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 30 Dec 2025 · 2 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #88 · Analytics › COA interpretation · 12 Dec 2025 · 1 like This follows post #87 rather than contradicting it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
-
The most useful thing you learned here that was not the answer you came for Replied, post #5 · Lounge › Off topic · 25 Nov 2025 · 2 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Comparing two chromatograms from different laboratories, properly Replied, post #26 · Analytics › HPLC & UHPLC · 2 Nov 2025 · 2 likes Post #24 put the caveat in the right place and I want to underline it. System suitability is not paperwork. If the replicate injections failed, the run did not happen —…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #63 · Analytics › COA interpretation · 2 Nov 2025 · 20 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Cost per delivered dose, which is the number that matters Replied, post #18 · Access › Pricing · 30 Oct 2025 · 13 likes Nothing here is financial advice and none of it is a route to a transaction. Not the whole picture, but the part of it I can speak to.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #53 · Compounds › Oral incretins · 24 Oct 2025 · 11 likes Post #52 answers the question as asked. The question underneath it is different. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
-
New subcategory: rationale and scope Replied, post #100 · Meta › Announcements · 23 Oct 2025 · 26 likes Picking up post #97: that is the part I would want checked first. New subcategory would be much easier to settle if anyone reported the denominator. Almost nobody…
-
About the Pharmacokinetics category Replied, post #3 · Pharmacology › Pharmacokinetics · 20 Oct 2025 · 20 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
A 40-week log with the measurement method stated Started this topic · Outcomes › Progress reports · 11 Oct 2025 · 16 likes On the subject in the title: A 40-week log with the measurement method stated Working notes rather than a conclusion. Asking about 40-week log directly, because I have…
-
[2026 update] Splitting an overlong document into two Replied, post #39 · Documentation › Wiki requests · 8 Oct 2025 · 0 likes Narrowing post #36, because the general version has more than one answer. A document with no maintainer becomes wrong quietly, which is worse than not existing, because…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #67 · Documentation › Doc review · 2 Oct 2025 · 22 likes Checked the Promotion criteria claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Realistic expectations for strength while losing weight quickly Replied, post #24 · Nutrition & Training › Resistance training · 28 Sep 2025 · 2 likes On realistic expectations for strength the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Thyroid function tests during substantial weight change Replied, post #70 · Clinical › Bloodwork · 22 Sep 2025 · 25 likes Post #68 and I disagree about the size of the effect, not about the direction. Glycaemic markers integrate over different periods. A point glucose and a longer-term…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #12 · Data & Tools › Calculators · 16 Sep 2025 · 13 likes This settles it for me, at least until somebody posts a reason it should not.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #39 · Evidence › Study critique · 13 Sep 2025 · 0 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #13 · Documentation › Doc review · 13 Sep 2025 · 2 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #34 · Practice › Storage & stability · 11 Sep 2025 · 28 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #46 · Practice › Storage & stability · 7 Sep 2025 · 0 likes Building on post #45 rather than restating it. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #93 · Evidence › Journal club · 23 Aug 2025 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
When a preprint is the best available evidence and we say so Replied, post #81 · Evidence › Preprints · 21 Aug 2025 · 25 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. The confident version…
-
Why the timeline is on the right and not the left Replied, post #54 · Meta › Site feedback · 14 Aug 2025 · 6 likes Bookmarking this. I will come back when I have something worth adding.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #82 · Compounds › Cagrilintide & amylin analogues · 12 Aug 2025 · 0 likes The bit of cagrisema phase 2 paper that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #109 · Practice › Reconstitution · 1 Aug 2025 · 22 likes One more thing on reconstituting a multi-strength kit that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you…
-
Coming back to: Official shortage notices and what they authorise Replied, post #73 · Access › Shortages · 30 Jul 2025 · 0 likes The arithmetic in post #72 is right; the assumption feeding it is the part to check. Supply interruptions: official shortage notices are published by regulatory…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #148 · Compounds › Tirzepatide · 27 Jul 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] Reverting an edit that had no revision note Replied, post #2 · Meta › Wiki maintenance · 19 Jul 2025 · 1 like Reverting an edit is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #2 · Meta › Announcements · 8 Jul 2025 · 0 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable. That distinction has done more work for me than…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #2 · Wellbeing › Mental health · 24 Jun 2025 · 0 likes Tracking mood alongside dose and weeks, on a simple scale, produces a record that is far more useful than a recollection at an appointment.
-
A report I filed that turned out to be wrong, and the correction Replied, post #95 · Sourcing › Vendor reports · 10 Jun 2025 · 0 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #47 · Clinical › Comorbidities · 6 Jun 2025 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Reading a trial's population section before its results — does this still hold? Replied, post #154 · Evidence › Trials · 27 May 2025 · 3 likes A comparator at less than its maximum licensed dose changes what a head-to-head result means. It does not invalidate the trial; it narrows the claim the trial supports.…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #102 · Practice › Interactions · 27 May 2025 · 3 likes Two sentences on delayed gastric emptying and oral and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #65 · Sourcing › Independent verification · 8 May 2025 · 21 likes Where an independent figure and a declared figure differ by less than method repeatability, that is agreement rather than a small discrepancy.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #61 · Practice › Reconstitution · 1 May 2025 · 19 likes Post #58 is right about the mechanism and I think understates the practical bit. 5 mg vial is a good example of a question where the honest answer is boring and the…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #71 · Access › Pricing · 19 Apr 2025 · 12 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Albumin binding and how it produces a long half-life Replied, post #26 · Pharmacology › Pharmacokinetics · 18 Apr 2025 · 24 likes I disagree with the framing of albumin binding above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
-
Which panel is worth repeating and which is worth ignoring Replied, post #2 · Clinical › Bloodwork · 9 Apr 2025 · 10 likes This follows the opening post rather than contradicting it. Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #18 · Practice › Dosing & titration · 3 Apr 2025 · 2 likes Narrowing post #15, because the general version has more than one answer. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #18 · Sourcing › Vendor reports · 30 Mar 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #39 · Evidence › Journal club · 12 Mar 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
About the Cold chain category Replied, post #4 · Devices › Cold chain · 1 Mar 2025 · 20 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #32 · Analytics › COA interpretation · 20 Jan 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #136 · Compounds › Oral incretins · 29 Dec 2024 · 8 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #60 · Practice › Side effects · 10 Dec 2024 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #10 · Evidence › Journal club · 26 Nov 2024 · 0 likes I would be cautious about generalising from the STEP 4 example above. It is a good example. It is one example.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #42 · Compounds › Semaglutide · 24 Nov 2024 · 13 likes STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second asks what happens when it is withdrawn after a run-in.…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #81 · Clinical › Prescriber conversations · 20 Nov 2024 · 0 likes Ask what the follow-up plan is and when the next review is. That single question prevents most of the drift people report here.
-
Fixed versus detachable needles: the trade-offs Replied, post #4 · Devices › Syringes & needles · 14 Nov 2024 · 13 likes Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the entire trade. The honest answer is that it…
-
Transporting a vial for a weekend away Replied, post #43 · Practice › Storage & stability · 9 Nov 2024 · 0 likes Thank you for the correction. I would rather find out here than later.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #12 · Access › Insurance & coverage · 2 Nov 2024 · 3 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #89 · Analytics › COA interpretation · 19 Oct 2024 · 10 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #106 · Nutrition & Training › Hydration & electrolytes · 20 Sep 2024 · 3 likes Helpful, and short, which on this subject is harder than long.